Skip to main content

Pharmacy news bulletins available on the portal

For a list of pharmacy news bulletins, pharmacists may sign in to the Pharmacist Portal. If you do not have access, you can register for a new account.

Additional notifications

Information about the launch of generic Mitigare

Effective Jan. 1, 2021, generic Mitigare (colchicine capsule) is not covered or may require step therapy on Humana’s Medicare Advantage prescription drug, Medicare Part D and commercial (including RxAdvantage) plans; brand Mitigare will continue to be covered and can be filled for the patient.

Prescribers with questions regarding this may call 800-555-CLIN (800-555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Generic Mitigare FAQs, PDF opens new window

Information about the launch of generic Vascepa

Effective Nov. 7, 2020, generic Vascepa (icosapent) is not covered on Humana’s Medicare Advantage prescription drug and Part D plans; brand Vascepa will continue to be covered and can be filled for the patient.

Prescribers with questions regarding this may call 800-555-CLIN (555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Generic Vascepa FAQs, PDF opens new window

Information about the launch of generic Tykerb

Effective Oct. 3, 2020, generic Tykerb (lapatinib) is not covered on Humana’s Medicare Advantage prescription drug and Part D plans; brand Tykerb will continue to be covered and can be filled for the patient.

Prescribers with questions regarding this may call 800-555-CLIN (555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Generic Tykerb FAQs, PDF opens new window

Information about the launch of generic Tecfidera

Effective Sept. 11, 2020, generic Tecfidera (dimethyl fumarate) is not covered on Humana’s Medicare Advantage prescription drug and Part D plans; brand Tecfidera will continue to be covered with prior authorization on all Medicare plans except the Walmart Value Part D plan and can be filled for the patient. Both brand and generic Tecfidera (dimethyl fumarate) will remain not covered on the Walmart Value Part D plan.

Prescribers with questions regarding this may call 800-555-CLIN (555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Generic Tecfidera FAQs , PDF opens new window

Point-of-sale edits for hydroxychloroquine and chloroquine – effective 7/1/20, PDF opens new window

Information about the launch of generic Symbicort HFA inhaler

Effective Jan. 11, 2020, generic Symbicort HFA inhaler (budesonide/formoterol HFA inhaler) is not covered or may require prior authorization for Medicare and commercial patients; brand Symbicort HFA inhaler will continue to be covered and can be filled for the patient.

Prescribers with questions regarding this may call 800-555-CLIN (555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Generic Symbicort HFA inhaler FAQs , PDF opens new window

Information about the launch of authorized generic insulin aspart and insulin aspart mix

Effective Dec. 14, 2019, authorized generics for NovoLog and NovoLog Mix (insulin aspart and insulin aspart mix) came to market. They are currently under evaluation for Humana’s Medicare Advantage prescription drug plans, Medicare Part D plans and commercial plans; brand NovoLog and NovoLog Mix will continue to be covered and can be filled for the patient.

Prescribers with questions regarding this may call 800-555-CLIN (555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Authorized generic insulin aspart and insulin aspart mix FAQs , PDF opens new window

Information about the launch of generic Afinitor

Effective Dec. 14, 2019, generic Afinitor (everolimus) is not covered on Humana’s Medicare Advantage prescription drug and Part D plans; brand Afinitor will continue to be covered with prior authorization and can be filled for the patient.

Prescribers with questions regarding this may call 800-555-CLIN (555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Generic Afinitor FAQs , PDF opens new window

Information about the launch of generic Jadenu

Effective Dec. 6, 2019, generic Jadenu (deferasirox) is not covered for Medicare patients; brand Jadenu will continue to be covered with prior authorization and can be filled for the patient.

Prescribers with questions regarding this may call 800-555-CLIN (555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Generic Jadenu FAQs , PDF opens new window

Information about the launch of generic Exjade

Effective April 1, 2019, generic Exjade (deferasirox) is not covered for Humana’s Medicare Advantage prescription drug plan and Part D plan members; brand Exjade will continue to be covered with prior authorization and can be filled for the patient.

Prescribers with questions regarding this may call 800-555-CLIN (555-2546), Monday through Friday, 8 a.m. to 8 p.m., Eastern time. Prescribers in Puerto Rico should call 866-488-5991.

Generic Exjade FAQs , PDF opens new window

Med-Edit update notification

As of Jan. 1, 2018, Humana Pharmacy Solutions made enhancements to the opioid utilization program point-of-sale edits based on the opioid thresholds below. Please note: Patients with cancer or in hospice will not be flagged for this edit.

Med-Edit Notification , PDF opens new window